Dr. Hsian-Rong Tseng is a Professor in the Department of Molecular & Medical Pharmacology at UCLA. He also holds memberships in the California NanoSystems Institute, Crump Institute for Molecular Imaging, and Jonsson Comprehensive Cancer Center on the UCLA campus. He has over 23 years of experience in organic chemistry, covering synthetic methodology, organometallic supramolecular and radiochemistry, as well as 14 years of experience in micro- and nanofabrication for applications in electronic and microfluidic devices. Over the past 10 years, Dr. Tseng’s group at UCLA has developed a series of nanotechnology- and microfluidics-enabled in vitro molecular diagnostic (IVMD) technologies with more than $15M funding support from National Institute of Health (NIH) and other funding organizations. These technologies are capable of: 1) quantifying single-cell signaling events, 2) measuring cell proliferation rates and metabolic phenotypes, and 3) capturing rare populations of cells (e.g., circulating tumor cells, CTCs) that are of significant value in cancer diagnoses. Dr. Tseng is the inventor of NanoVelcro CTC Assays, and one of the co-founders of CytoLumina since 2010. He is committed to translate the NanoVelcro CTC Assay from the research bench to oncology clinics with the help of his clinical collaborators.